Apr 24, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/Vertex-Pharmaceuticals-Vanza-Poised-to-Enter-Market-for-Cystic-Fibrosis-Treatment.jpg
628
1200
Vini Kothari
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Vini Kothari2024-04-24 15:21:272024-04-24 15:22:23Vertex Pharmaceuticals’ Vanza Poised to Enter Market for Cystic Fibrosis TreatmentApr 23, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/Meta-Microsoft-and-Alphabet_-April-2024-Earnings-Previews.jpg
628
1200
Melissa Otto, CFA
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Melissa Otto, CFA2024-04-23 09:32:112024-04-25 12:51:04Meta, Microsoft, and Alphabet: April 2024 Earnings PreviewsApr 22, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/The-Visible-Alpha-AI-Monitor_-Push-Towards-Enterprise-Adoption.jpg
628
1200
Melissa Otto, CFA
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Melissa Otto, CFA2024-04-22 10:12:072024-04-22 10:21:41The Visible Alpha AI Monitor: A Push Towards Enterprise AdoptionApr 17, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/Eli-Lillys-Donanemab-Treatment-for-Alzheimers-Faces-Regulatory-Approval-Delays.jpg
628
1200
Rahul Jasuja, PhD
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Rahul Jasuja, PhD2024-04-17 12:06:422024-04-17 12:06:42Eli Lilly’s Donanemab Treatment for Alzheimer’s Disease Faces Regulatory Approval DelaysApr 15, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/Indias-Telecom-Landscape-Jios-Rise-Airtels-ARPU-Surge-and-Vis-Downtrend.jpg
628
1200
Sweta Patra
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Sweta Patra2024-04-15 11:45:442024-04-15 11:59:29India’s Telecom Landscape: Jio’s Rise, Airtel’s ARPU Surge, and Vi’s DowntrendApr 10, 2024
https://visiblealpha.com/wp-content/uploads/2024/04/Will-Google-Cloud-Achieve-a-Double-Digit-Profit-Margin-in-2025.jpg
628
1200
Melissa Otto, CFA
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Melissa Otto, CFA2024-04-10 11:00:432024-04-10 11:10:11Will Google Cloud Achieve a Double-Digit Profit Margin in 2025?Mar 19, 2024
https://visiblealpha.com/wp-content/uploads/2024/03/Takeda-Pharmaceuticals-Qdenga-Dengue-Vaccine-Poised-for-Strong-Growth.jpg
628
1200
Ashutosh Raj
/wp-content/uploads/2019/09/visible-alpha-logo1.png
Ashutosh Raj2024-03-19 15:27:562024-03-19 15:27:56Takeda Pharmaceutical’s Qdenga Dengue Vaccine Poised for Strong GrowthGet it Delivered
Get articles like these including investment research news and insights uncovered using the Visible Alpha platform delivered to your inbox.
Call Us
General Inquiries: +1 646 374 4702
Sales
Americas: +1 646 989-2621
Europe: +44 20 35451032
APAC: +852 3002 0647
Client Support
Americas: +1 646 462 3210
Europe: +44 20 3884 2798
APAC: +852 3002 0649